Pharmaceutical Economy In China Sees Steady Growth
This article was originally published in PharmAsia News
Executive Summary
According to recent statistics, total purchases of the top seven medical products in China were RMB 192.6 billion from January to June, an increase of 10.74 percent compared to the same period last year. Among them, pharmaceutical products accounted for RMB 147.2 billion, up 11.85 percent; and medical devices, in the amount of RMB 2.4 billion, increased 1.27 percent. The total sales were RMB 213.7 billion, 11.66 percent more than the same period last year. The areas that took the lead in sales were Shanghai, Beijing, Zhejiang, Guangdong, Jiangsu and Anhui. Total sales in these regions account for 62 percent of China's total sales. (Click here for more - Chinese lanugage)
You may also be interested in...
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.
Sanofi Skates To Where The Puck Is With Immunology
The French drugmaker has not abandoned oncology but has made it very clear that immunology and inflammation is the priority for its R&D euros.